Evidence map›Paper›PMID 37486145›Full record

ArticlePediatric blood & cancer2023

Children's Oncology Group's 2023 blueprint for research: Radiation oncology.

John A Kalapurakal, Suzanne L Wolden, Daphne Haas-Kogan, Nadia N Laack, Chia-Ho Hua, Arnold C Paulino, Christine E Hill-Kayser, Bradford S Hoppe, Thomas J Fitzgerald, COG Radiation Oncology Discipline Committee

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric blood & cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

John A KalapurakalNorthwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Suzanne L WoldenMemorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0002-5234-4134
Daphne Haas-KoganHarvard Medical School, Boston, Massachusetts, USA.
Nadia N LaackMayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-4385-6349
Chia-Ho HuaSt. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-6642-4004
Arnold C PaulinoM.D. Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-0269-3045
Christine E Hill-KayserUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-1993-1185
Bradford S HoppeMayo Clinic, Jacksonville, Florida, USA.ORCID 0000-0002-2312-5418
Thomas J FitzgeraldUniversity of Massachusetts, Worcester, Massachusetts, USA.ORCID 0000-0002-6256-0615
COG Radiation Oncology Discipline Committee
Harvard University · USJacksonville College · USMayo Clinic · USMemorial Sloan Kettering Cancer Center · USNorthwestern University · USSt. Jude Children's Research Hospital · USThe University of Texas MD Anderson Cancer Center · USUniversity of Massachusetts Chan Medical School · USUniversity of Pennsylvania · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DEVIDAS, MEENAKSHI · 2003 to 2013
$67.5M
NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NCI NIH HHS U24 CA180803NIH HHS 1U24CA180803NIH HHS U10CA098413NIH HHS U10CA098543NIH HHS U10CA180886
6 · The paper itself

Abstract

Radiation oncology is an integral part of the multidisciplinary team caring for children with cancer. The primary goal of our committee is to enable the delivery of the safest dose of radiation therapy (RT) with the maximal potential for cure, and to minimize toxicity in children by delivering lower doses to normal tissues using advanced technologies like intensity-modulated RT (IMRT) and proton therapy. We provide mentorship for y ators and are actively involved in educating the global radiation oncology community. We are leaders in the effort to discover novel radiosensitizers, radioprotectors, and advanced RT technologies that could help improve outcomes of children with cancer.

Indexed as

NeoplasmsRadiation OncologyRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedChildHumansMedical Oncologychemotherapylate effects of cancer treatmentlong-term survivalmolecular biologyradiation therapy

Identifiers

PMID37486145
PMCPMC10588230
OpenAlexW4385185753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.